945950-45-8 Usage
Description
(S)-3,3-dimethyl-2,3-dihydro-1H-inden-1-amine, also known as L-Indanamine, is a chiral amine compound characterized by its molecular formula of C11H15N. It features a chiral center, which is crucial for its role as an intermediate in the synthesis of various chiral drugs and complex molecules. This chemical is recognized for its versatility and significance in multiple industries, including pharmaceuticals, agriculture, and the chemical industry.
Uses
Used in Pharmaceutical Industry:
(S)-3,3-dimethyl-2,3-dihydro-1H-inden-1-amine is used as a building block in organic synthesis for the development of pharmaceuticals. Its chiral nature makes it an important precursor in the creation of chiral drugs, which are essential for their specific therapeutic effects and reduced side effects.
Used in Agricultural Industry:
In the agricultural sector, (S)-3,3-dimethyl-2,3-dihydro-1H-inden-1-amine is utilized as a precursor in the manufacturing of agrochemicals. Its role in this industry is vital for the development of effective and targeted pest control solutions, contributing to increased crop yields and reduced environmental impact.
Used in Chemical Industry:
(S)-3,3-dimethyl-2,3-dihydro-1H-inden-1-amine also finds application in the chemical industry as a key intermediate for the synthesis of fragrance compounds. Its unique properties allow for the creation of complex and diverse scents used in the production of perfumes, cosmetics, and other fragrance-based products.
Check Digit Verification of cas no
The CAS Registry Mumber 945950-45-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,5,9,5 and 0 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 945950-45:
(8*9)+(7*4)+(6*5)+(5*9)+(4*5)+(3*0)+(2*4)+(1*5)=208
208 % 10 = 8
So 945950-45-8 is a valid CAS Registry Number.
945950-45-8Relevant articles and documents
Heteroaryl compounds useful as inhibitors of E1 activating enzymes
-
, (2008/06/13)
This invention relates to compounds that inhibit E1 activating enzymes, pharmaceutical compositions comprising the compounds, and methods of using the compounds. The compounds are useful for treating disorders, particularly cell proliferation disorders, including cancers, inflammatory and neurodegenerative disorders; and inflammation associated with infection and cachexia.
